Published in Am J Med on November 01, 1978
Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2011) 1.57
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes. Am J Physiol Heart Circ Physiol (2008) 1.54
Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev (2011) 1.50
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest (1981) 1.46
Tumor detection and elimination by a targeted gallium corrole. Proc Natl Acad Sci U S A (2009) 1.34
High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin. Proc Natl Acad Sci U S A (1996) 1.11
Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer. Curr Oncol (2008) 1.00
Lipid lowering: an important factor in preventing adriamycin-induced heart failure. Am J Pathol (1997) 0.95
Adriamycin (doxorubicin) cardiotoxicity: a review. West J Med (1979) 0.93
Cardiac damage induced by 2-amino-3-methyl-imidazo[4,5-f]quinoline in nonhuman primates. Environ Health Perspect (1994) 0.92
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol (2012) 0.91
Rodent models of heart failure: an updated review. Heart Fail Rev (2013) 0.85
NAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes. Cardiovasc Toxicol (2012) 0.83
Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity. Cancer Res Treat (2008) 0.83
Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity. Eur J Histochem (2012) 0.81
Ataxia telangiectasia mutated in cardiac fibroblasts regulates doxorubicin-induced cardiotoxicity. Cardiovasc Res (2016) 0.80
Protective effect of melatonin against Adriamycin-induced cardiotoxicity. Exp Ther Med (2013) 0.80
Adriamycin and altered membrane functions in rat hearts. Br J Exp Pathol (1986) 0.80
Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients. PLoS One (2016) 0.80
Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity. Biochim Biophys Acta (2008) 0.80
Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker. Br J Cancer (1994) 0.79
A method for detection of doxorubicin-induced cardiotoxicity: Flow-mediated vasodilation of the brachial artery. Exp Clin Cardiol (2001) 0.78
Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors. Invest New Drugs (2015) 0.77
p21(WAF1/Cip1/Sdi1) knockout mice respond to doxorubicin with reduced cardiotoxicity. Toxicol Appl Pharmacol (2011) 0.77
Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. Am J Pathol (1984) 0.77
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction. Am Heart J (2012) 0.77
Nano-enabled delivery of diverse payloads across complex biological barriers. J Control Release (2015) 0.76
Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits. Am J Pathol (1987) 0.76
Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer. J Am Heart Assoc (2015) 0.76
The development of congestive heart failure and ventricular tachycardia after first exposure to idarubicin in a patient with acute myeloid leukaemia. Br J Clin Pharmacol (2010) 0.75
Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia. Leuk Res Rep (2017) 0.75
Cardiotoxicity associated with targeted cancer therapies. Mol Clin Oncol (2016) 0.75
Clinical vignettes: integrated care of cancer patients by oncologists and cardiologists. Curr Cardiol Rev (2011) 0.75
Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment. Ann Transl Med (2017) 0.75
Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. J Pediatr Hematol Oncol (2017) 0.75
Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 19.60
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med (1996) 12.77
Corticocortical inhibition in human motor cortex. J Physiol (1993) 8.92
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
Physical activity and the incidence of coronary heart disease. Annu Rev Public Health (1987) 6.76
An artificial standard for use in the estimation of haemoglobin. Biochem J (1945) 6.45
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses. J Physiol (1989) 5.69
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res (1998) 4.27
Acrasin, Acrasinase, and the sensitivity to acrasin in Dictyostelium discoideum. Dev Biol (1969) 3.56
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med (2001) 3.44
Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation (1999) 3.35
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 3.32
Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med (1991) 3.26
Ultrasonic cardiac echography for determining stroke volume and valvular regurgitation. Circulation (1970) 3.22
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20
Stimulation of the human motor cortex through the scalp. Exp Physiol (1991) 3.16
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14
ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14
Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol (1995) 3.12
Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (1993) 3.10
Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res (2000) 3.08
Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med (1974) 2.89
Motor cortex stimulation in intact man. 2. Multiple descending volleys. Brain (1987) 2.77
Botulinum toxin in spasmodic torticollis. J Neurol Neurosurg Psychiatry (1988) 2.74
Human walking and higher-level gait disorders, particularly in the elderly. Neurology (1993) 2.65
Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep (1978) 2.63
Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA (1982) 2.62
Congestive heart failure: fifty years of progress. Circulation (2000) 2.61
Physical fitness levels vs selected coronary risk factors. A cross-sectional study. JAMA (1976) 2.57
The pathophysiology of primary dystonia. Brain (1998) 2.51
Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med (1967) 2.41
The Saccharomyces cerevisiae actin-related protein Arp2 is involved in the actin cytoskeleton. J Cell Biol (1996) 2.40
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med (1993) 2.39
Myosin heavy chain gene expression in human heart failure. J Clin Invest (1997) 2.39
Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am J Psychiatry (1995) 2.39
A study of hereditary essential tremor. Brain (1994) 2.37
Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. J Neurol Neurosurg Psychiatry (1986) 2.37
Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant (1994) 2.36
Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology (1992) 2.36
Abnormalities in central motor pathway conduction in multiple sclerosis. Lancet (1984) 2.30
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation (1983) 2.24
Pathophysiology of bradykinesia in Parkinson's disease. Brain (2001) 2.24
The long-term follow-up of patients undergoing saphenous vein bypass surgery. Circulation (1974) 2.19
Delay in the execution of voluntary movement by electrical or magnetic brain stimulation in intact man. Evidence for the storage of motor programs in the brain. Brain (1989) 2.19
Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18
Some recent advances in cardiac pathology. Hum Pathol (1979) 2.17
Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol (1980) 2.17
The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation (1974) 2.16
Ultrasound for the diagnosis of atrial tumor. Ann Intern Med (1969) 2.16
New yeast actin-like gene required late in the cell cycle. Nature (1992) 2.12
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain (2000) 2.11
Assessing VO2max in epidemiologic studies: modification of the Astrand-Rhyming test. Med Sci Sports Exerc (1982) 2.11
Corticobasal degeneration. A clinical study of 36 cases. Brain (1994) 2.10
Interaction of plasma kallikrein with the C1 inhibitor. J Immunol (1970) 2.07
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest (1992) 2.07
Amiodarone. N Engl J Med (1987) 2.05
Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum (2000) 2.01
Modulation of motor cortical excitability by electrical stimulation over the cerebellum in man. J Physiol (1991) 2.01
Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation (1996) 2.01
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr (1997) 1.98
Motor cortex stimulation in intact man. 1. General characteristics of EMG responses in different muscles. Brain (1987) 1.98
Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation (1986) 1.97
Advances in the understanding of myocarditis. Circulation (2001) 1.93
Percutaneous electrical stimulation of corticospinal pathways at the level of the pyramidal decussation in humans. Ann Neurol (1991) 1.93
Assessing tremor severity. J Neurol Neurosurg Psychiatry (1993) 1.92
Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant (1990) 1.91
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest (1984) 1.91
Effect of vision and stance width on human body motion when standing: implications for afferent control of lateral sway. J Physiol (1993) 1.91
Propranolol in patients with angina pectoris. Ann Intern Med (1967) 1.90
Models of arthritis and the search for anti-arthritic drugs. Pharmacol Ther (1983) 1.90
Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man. Circulation (1971) 1.88
Import of nuclear deoxyribonucleic acid coded lysine-accepting transfer ribonucleic acid (anticodon C-U-U) into yeast mitochondria. Biochemistry (1979) 1.86
Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86
American College of Sports Medicine position stand. Heat and cold illnesses during distance running. Med Sci Sports Exerc (1996) 1.86
Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest (1988) 1.85
Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation (1997) 1.84
Different sites of action of electrical and magnetic stimulation of the human brain. Neurosci Lett (1987) 1.84
ACC/AHA guidelines for exercise testing: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation (1997) 1.83
Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82
Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med (1983) 1.81
Cardiovascular benefits and assessment of physical activity and physical fitness in adults. Med Sci Sports Exerc (1992) 1.81
Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation (1997) 1.81
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
Botulinum toxin treatment of spasmodic torticollis. J R Soc Med (1992) 1.81
Transesophageal echocardiography and its potential for esophageal damage. Anesthesiology (1990) 1.80